[1] Tian Z, Li L, Wang L, et al. Salivary gland neoplasms in oral and maxillofacial regions: a 23-year retrospective study of 6982 cases in an eastern Chinese population [J]. Int J Oral Maxillofac Surg, 2010, 39(3): 235-242. [2] 邹会会,徐文光,尹西腾,等.基于SEER数据库分析影响大唾液腺腺样囊性癌患者预后的临床病理因素[J].口腔医学研究,2020,36(2):167-171. [3] Cordesmeyer R, Laskawi R, Schliephake H, et al. Shallow whole genome sequencing of. adenoid cystic carcinomas of the salivary glands identifies specific chromosomal aberrations related to tumor progression [J]. Oral Oncol, 2020, 103:104615. [4] Nath S, Mukherjee P. MUC1: a multifaceted oncoprotein with a key role in cancer progression [J]. Trends Mol Med, 2014, 20(6):332-342. [5] 许宁,朱恩新,张茜,等.CyclinD1和Ki67与涎腺腺样囊性癌发生及预后的相关性研究[J].口腔医学研究,2020,26(1):22-25. [6] Gendler SJ. MUC1, the renaissance molecule [J]. J Mammary Gland Biol Neoplasia, 2001, 6(3):339-353. [7] Rahn J. The importance of MUC1 cellular localization in patients with breast carcinoma: an. immunohistologic study of 71 patients and review of the literature [J]. Cancer, 2001, 91(11):1973-1982. [8] Wang L, Ma J, Liu FH, et al. Expression of MUC1 in primary and metastatic human. epithelial ovarian cancer and its therapeutic significance [J]. Gynecol Oncol, 2007, 105(3):695-702. [9] Hamada T, Nomura M, Kamikawa Y, et al. DF3 epitope expression on MUC1 mucin is. associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma [J]. Cancer, 2012, 118(21):5251-5264. [10] Liu X, Caffrey TC, Steele MM, et al. MUC1 regulates cyclin D1 gene expression through. p120 catenin and β-catenin [J]. Oncogenesis, 2014, 3(6): e107. [11] Gnemmi V, Bouillez A, Gaudelot K, et al. MUC1 drives epithelial-mesenchymal transition in renal. carcinoma through Wnt/β-catenin pathway and interaction with SNAIL promoter [J]. Cancer Lett, 2014, 346(2): 225-236. [12] Rajabi H, Alam M, Takahashi H, et al. MUC1-C oncoprotein activates the ZEB1/miR-200c regulatory loop and epithelial-mesenchymal transition[J]. Oncogene, 2014, 33(13): 1680-1689. [13] Roy LD, Sahraei M, Subramani DB, et al. MUC1 enhances invasiveness of pancreatic. cancer cells by inducing epithelial to mesenchymal transition [J]. Oncogene, 2011, 30(12):1449-1459. [14] Schlessinger J. Receptor tyrosine kinases: legacy of the first two decades [J]. Cold Spring Harb Perspect Biol, 2014, 6(3): a008912. [15] Lemmon MA, Schlessinger J, Ferguson KM. The EGFR family: not so prototypical receptor tyrosine kinases [J]. Cold Spring Harb Perspect Biol, 2014, 6(4): a020768. [16] Schroeder JA, Thompson MC, Gardner MM, et al. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland[J]. J Biol Chem, 2001, 276(16): 13057-13064. [17] Alam M, Ahmad R, Rajabi H, et al. MUC1-C oncoprotein activates ERK→C/EBPβ signaling and induction of aldehyde dehydrogenase 1A1 in breast cancer cells[J]. J Biol Chem, 2013, 288(43): 30892-30903. |